Physician profile
Scott Burgess
NPI 1609854835
$6,777.58
in general payments reported to CMS, 2019-2025
36 companies · $2,909 in 2025
The $2,909 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,880 · 2020: $221 · 2021: $54.44 · 2022: $188 · 2023: $16.32 · 2024: $508 · 2025: $2,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,211 · Travel and Lodging: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,210.78 |
| Travel and Lodging | $1,222.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,978.69 | 2019-2025 | |
| Procept Biorobotics Corporation | $1,530.05 | 2025 | |
| Olympus America INC. | $1,350.64 | 2019-2025 | Itind System, Olympus, Soltive |
| Astellas Pharma US INC | $448.97 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $214.45 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $190.98 | 2020-2025 | Lithovue, Lumenis Pulse 100h |
| Endo Pharmaceuticals INC. | $102.04 | 2019-2020 | |
| Blue Earth Diagnostics | $78.93 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $77.14 | 2019-2020 | |
| Accord Healthcare, INC. | $69.02 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.06 | 2021-2025 | Entyvio |
| Antares Pharma, INC. | $50.87 | 2019 | |
| Allergan, INC. | $48.63 | 2019 | |
| Pfizer INC. | $45.63 | 2019-2020 | |
| Photocure INC | $39.64 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $39.17 | 2019 | |
| Valencia Technologies Corporation | $39.14 | 2025 | Ecoin Device Kit |
| Dentsply Ih INC. | $38.79 | 2019-2020 | |
| Medtronic USA, INC. | $37.61 | 2019 | |
| Coloplast Corp | $35.05 | 2019-2024 | |
| Ethicon US, LLC | $31.62 | 2025 | Vistaseal |
| 180 Medical, INC. | $27.33 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $26.98 | 2025 | Iqirvo |
| Zyla Life Sciences, INC. | $25.24 | 2019 | |
| Janssen Biotech, INC. | $23.08 | 2019 | |
| Cook Medical LLC | $22.79 | 2025 | Litho 150 |
| Davol INC. | $21.01 | 2020 | |
| Axonics, INC. | $20.65 | 2021 | |
| Teleflex LLC | $19.83 | 2024 | Urolift |
| Abbvie INC. | $19.00 | 2019 | |
| Merck Sharp & Dohme LLC | $17.88 | 2025 | Bridion |
| Urogen Pharma, INC. | $16.04 | 2021 | |
| Mission Pharmacal Company | $13.97 | 2019 | |
| Neotract INC. | $10.79 | 2019 | |
| Erbe USA INC | $5.00 | 2025 | Erbevio3/Apc3 |
| Histosonics, INC. | $4.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Burgess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.